Pak Fah Yeow International Limited

239 BMG6873Y1176

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 04:09:09 2024-04-25 am EDT			5-day change	1st Jan Change
2.07 ^HKD	+2.99%		+0.98%	+16.95%

Mar. 26	Pak Fah Yeow International Limited Proposes Special Final Dividend for the Year Ended 31 December 2023, Payable on 12 August 2024	CI
Mar. 26	Pak Fah Yeow International Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 12 August 2024	CI

Pak Fah Yeow International Limited Approves Final Dividend for the Year Ended 31 December 2020

June 11, 2021 at 04:58 am EDT

Pak Fah Yeow International Limited approved final dividend of 3.8 Hong Kong cents per share for the year ended 31 December 2020 at the annual general meeting of the Company held on 11 June 2021.

Latest news about Pak Fah Yeow International Limited

Pak Fah Yeow International Limited Proposes Special Final Dividend for the Year Ended 31 December 2023, Payable on 12 August 2024	Mar. 26	CI
Pak Fah Yeow International Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 12 August 2024	Mar. 26	CI
Pak Fah Yeow International Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 26	CI
Pak Fah Yeow International Forecasts Attributable Profit to Triple in 2023	Mar. 08	MT
Pak Fah Yeow International Limited Provides Earnings Guidance for the Year Ended 31 December 2023	Mar. 07	CI
Pak Fah Yeow International Limited Appoints Gan Fook Yin, Anita as Member of Nomination Committee	Dec. 07	CI
Pak Fah Yeow International Limited Announces Interim Dividend for the Six Months Ended 30 June 2023, Payable on 08 December 2023	23-08-30	CI
Pak Fah Yeow International Limited Announces Special Interim Dividend for the Year Ending 31 December 2023, Payable on December 8, 2023	23-08-30	CI
Pak Fah Yeow International Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-30	CI
Pak Fah Yeow to Swing to Profit in H1	23-07-07	MT
Pak Fah Yeow International Limited Provides Earnings Guidance for the Six Months Ending 30 June 2023	23-07-07	CI
Pak Fah Yeow International Limited Declares Special Dividend for the Year Ended 31 December 2022	23-06-07	CI
Pak Fah Yeow International Limited Declares Final Dividend for the Year Ended 31 December 2022	23-06-07	CI
Pak Fah Yeow International Limited Proposes Special Dividend for the Year Ended 31 December 2022 Payable on 11 August 2023	23-03-30	CI
Pak Fah Yeow International Limited Proposes Final Dividend for the Year Ended 31 December 2022 Payable on 11 August 2023	23-03-30	CI
Pak Fah Yeow International Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30	CI
Pak Fah Yeow Expects Lower 2022 Profit	23-03-21	MT
Pak Fah Yeow International Limited Provides Earnings Guidance for the Year Ended 31 December 2022	23-03-17	CI
Pak Fah Yeow International Limited Announces Board Changes	22-09-30	CI
Pak Fah Yeow International Limited Declares Interim Dividend for the Year Ending December 31, 2022, Payable on or About December 9, 2022	22-08-31	CI
Pak Fah Yeow International Limited Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-31	CI
Pak Fah Yeow International Limited Provides Earnings Guidance for the Six Months Ended 30 June 2022	22-08-23	CI
Pak Fah Yeow International Limited Approves Special Dividend for the Year Ended 31 December 2021	22-06-30	CI
Pak Fah Yeow International Limited Approves Final Dividend for the Year Ended 31 December 2021	22-06-30	CI
Pak Fah Yeow International Limited Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-31	CI

Chart Pak Fah Yeow International Limited

Duration

Period

Chart Pak Fah Yeow International Limited

More charts

Pak Fah Yeow International Ltd is an investment holding company principally engaged in the manufacture and sale of healthcare products. The Company operates through three segments. The Healthcare segment is engaged in the manufacture and sales of healthcare products under the brand names of Hoe Hin products. The Property Investment segment is engaged in the investment in commercial, office, industrial and residential properties. The Treasury Investment segment is engaged in the equity and debt securities, mutual funds and dual currency investments businesses.

Sector

Pharmaceuticals

Calendar

2024-08-27 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
PAK FAH YEOW INTERNATIONAL LIMITED	+16.95%	79.97M
OTSUKA HOLDINGS CO., LTD.	+18.59%	22.25B
SANDOZ GROUP AG	+13.49%	14.39B
CIPLA LIMITED	+12.83%	13.55B
ZYDUS LIFESCIENCES LIMITED	+38.02%	11.27B
ONO PHARMACEUTICAL CO., LTD.	-9.80%	6.95B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+6.29%	5.01B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	-5.36%	4.51B